Multiple sclerosis in Japan appears to be a milder disease compared to the UK

Journal of Neurology

Volumn 262, Issue 4, 2015, Pages 831-836

  Piccolo, L ^a,d   Kumar, G ^a   Nakashima, I ^b   Misu, T ^c   Kong, Y ^a   Wakerley, B ^a   Ryan, S ^a   Cavey, A ^a   Fujihara, K ^c   Palace, Jacqueline ^a  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF PAVIA   (Italy)

Author keywords

Disability; Disease modifying treatments; Multiple sclerosis; Prognosis

Indexed keywords

ADULT; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; HUMAN; JAPAN; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; SEVERITY OF ILLNESS INDEX; UNITED KINGDOM; YOUNG ADULT;

ADULT; COHORT STUDIES; FEMALE; GREAT BRITAIN; HUMANS; JAPAN; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84939955050     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-015-7637-3     Document Type: Article

References (28)

1. Ascherio A, Munger K (2008) Epidemiology of multiple sclerosis: from risk factors to prevention. Semin Neurol 28(1):17–28
2. Wang H, Munger KL, Reindl M et al (2008) Myelin oligodendrocyte glycoprotein antibodies and multiple sclerosis in healthy young adults. Neurology 71(15):1142–1146
3. Faridar A, Eskandari G, Sahraian MA et al (2012) Vitamin D and multiple sclerosis: a critical review and recommendations on treatment. Acta Neurol Belg 112(4):327–333
4. Levin LI, Munger KL, O’Reilly EJ et al (2010) Primary infection with the Epstein–Barr virus and risk of multiple sclerosis. Ann Neurol 67(6):824–830
5. Alonso A, Hernán MA (2008) Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology 71(2):129–135
6. Koutsouraki E, Costa V, Baloyannis S (2010) Epidemiology of multiple sclerosis in Europe: a review. Int Rev Psychiatry 22(1):2–13
7. Kira J (2003) Multiple sclerosis in the Japanese population. Lancet Neurol 2(2):117–127
8. Wasay M, Khatri IA, Khealani B, Sheerani M (2006) MS in Asian countries. Int MS J 13(2):58–65
9. Houzen H, Niino M, Kikuchi S et al (2003) The prevalence and clinical characteristics of MS in northern Japan. J Neurol Sci 211(1–2):49–53
10. Detels R, Visscher BR, Malmgren RM et al (1977) Evidence for lower susceptibility to multiple sclerosis in Japanese-Americans. Am J Epidemiol 105(4):303–310
11. Nakashima I, Fujihara K, Okita N et al (1999) Clinical and MRI study of brain stem and cerebellar involvement in Japanese patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 67(2):153–157
12. Osoegawa M, Kira J, Fukazawa T et al (2009) Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years. Mult Scler 15(2):159–173
13. Houzen H, Niino M, Hirotani M et al (2012) Increased prevalence, incidence, and female predominance of multiple sclerosis in northern Japan. J Neurol Sci 323(1–2):117–122
14. Chong HT, Tan CT (2008) A review of multiple sclerosis with Asian perspective. Med J Malaysia 63(5):356–361
15. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13(3):227–231
16. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444–1452
17. Table of MSSS scores derived from EDSS. https://www-gene.cimr.cam.ac.uk/MSgenetics/GAMES/MSSS/MSSS-table
18. Multiple Sclerosis Severity Score (2007). https://www-gene.cimr.cam.ac.uk/MSgenetics/GAMES/MSSS/Readme
19. Strange RC, Ramachandran S, Zeegers MP et al (2010) The Multiple Sclerosis Severity Score: associations with MC1R single nucleotide polymorphisms and host response to ultraviolet radiation. Mult Scler 16(9):1109–1116
20. Pachner AR, Steiner I (2009) The multiple sclerosis severity score (MSSS) predicts disease severity over time. J Neurol Sci 278(1–2):66–70
21. Tanaka K, Kujuro Y, Suzuki S et al (2005) Clinical and laboratory features of in-patients with multiple sclerosis in a University Hospital in Tokyo from 1988–2002. Intern Med 44(6):560–566
22. Chan KH, Tsang KL, Ho PW et al (2011) Clinical outcome of relapsing remitting multiple sclerosis among Hong Kong Chinese. Clin Neurol Neurosurg 113(8):617–622
23. Lau KK, Wong WW, Sheng B et al (2008) The clinical course of multiple sclerosis patients in Hong Kong. J Neurol Sci 268(1–2):78–82
24. Chang KH, Lyu RK, Chen CM et al (2006) Clinical characteristics of multiple sclerosis in Taiwan: a cross-sectional study. Mult Scler 12(4):501–506
25. Matsuoka T, Matsushita T, Kawano Y et al (2007) Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 130(Pt 5):1206–1223
26. Gale CR, Martyn CN (1995) Migrant studies in multiple sclerosis. Prog Neurobiol 47(4–5):425–448
27. Roxburgh RH, Seaman SR, Masterman T, Hensiek AE, Sawcer SJ, Vukusic S, Achiti I, Confavreux C, Coustans M, le Page E, Edan G, McDonnell GV, Hawkins S, Trojano M, Liguori M, Cocco E, Marrosu MG, Tesser F, Leone MA, Weber A, Zipp F, Miterski B, Epplen JT, Oturai A, Sørensen PS, Celius EG, Lara NT, Montalban X, Villoslada P, Silva AM, Marta M, Leite I, Dubois B, Rubio J, Butzkueven H, Kilpatrick T, Mycko MP, Selmaj KW, Rio ME, Sá M, Salemi G, Savettieri G, Hillert J, Compston DA (2005) Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 64(7):1144–1151
28. Kitley J, Leite MI, Nakashima I, Waters P, McNeillis B, Brown R, Takai Y, Takahashi T, Misu T, Elsone L, Woodhall M, George J, Boggild M, Vincent A, Jacob A, Fujihara K, Palace J (2012) Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan. Brain. 135(Pt 6):1834–1849